# Injective Marks Canary Funds’ INJC ETF at Nasdaq Opening Bell

By Enna Lee

Canonical URL: https://www.tokenpost.com/news/investing/51700
Published: 2026-11-08T16:59:24.000Z
Updated: 2026-11-08T16:59:24.000Z
Section: Investing

> The Canary Funds product is the first U.S. ETF to track INJ. BitGo holds its spot tokens, and the fund plans to stake up to 90% of its holdings.

Injective marked Canary Funds' INJC exchange-traded fund at Nasdaq's opening bell, celebrating the listing of a U.S.-traded product that combines exposure to Injective (INJ) with staking.

INJC is the fund's ticker, not a separate crypto token. It is the first U.S. ETF to track INJ, and the [fund's Nasdaq listing](<https://www.tokenpost.com/news/investing/51140>) gives investors access to the product through a standard brokerage account.

BitGo holds the fund's spot INJ. The product plans to stake up to 90% of its holdings and automatically reinvest net staking proceeds.

Injective is a decentralized layer-1 blockchain designed for trading and decentralized finance applications.



## Links in this article

- [fund's Nasdaq listing](https://www.tokenpost.com/news/investing/51140)
